+41-61-487-12-12 info@buhlmannlabs.ch

UEG Week 2024 - Welcome to Vienna!

Come and interact with the Inflammatory Bowel Disease community at the UEGW 2024, taking place from October 12th to 15th, 2024, in Vienna!

BÜHLMANN provides a broad range of fecal calprotectin products for both laboratories and patient care. Additionally, our Quantum Blue® Point of Care reader offers a complete quick testing solution for anti-TNFα biologics and their antibodies.

BÜHLMANN Highlights at UEGW 2024

IBDoc® Calprotectin Home Test now IVDR approved

IBDoc® is a user-friendly home testing device designed for the quantitative assessment of fecal calprotectin levels. With simple steps, it enables the remote monitoring of calprotectin levels in IBD patients from the comfort of their own homes. And, with this new certification, we can ensure that IBDoc® meets the highest standards of safety, performance and quality. This is a major milestone for home testing as an innovative solution for remote management of IBD.

Read more

IBDoc® Success Story

Professor Patrick van Rheenen, a distinguished pediatrician based at the University Medical Center Groningen (UMCG) in the Netherlands, shared insights into the seamless incorporation of the IBDoc® fecal calprotectin home test into a hospital’s remote monitoring system. This achievement was made possible through the utilization of the standard HL7 communication pathway .

Read more

New CALEX® Cap Stool Collection Set Tutorial Video

The CALEX® Cap Collection Set offers a convenient solution for patients to collect stool samples at home. The CALEX® Cap extraction device enables the measurement of both fecal calprotectin and pancreatic elastase from a single extraction tube.

Read more

Quantum Blue® therapy monitoring (TDM) Success Story

The Quantum Blue® rapid tests offer an easy way to perform therapy monitoring (TDM) of anti-TNFα biologics. Read about the experience of our customers using the system successfully in their daily routine.

Read more
Contact us

BÜHLMANN E-Poster

to be published and presented at UEGW 2024

PP1122 Clinical performance of an automated turbidimetric immunoassay to quantify fecal pancreatic elastase 

View abstract of the poster

Christian REINHARD
Head POC & Self-Testing

Leslie ANCHLING
Product Manager Point of Care

Romain PÉNAGER
Product Manager Self-Testing

Schedule a meeting
Schedule a meeting
Schedule a meeting

Calprotectin in IBD Diagnosis and Monitoring

Inflammatory Bowel Disease (IBD), which includes Crohn’s Disease (CD) and Ulcerative Colitis (UC), are serious and chronic conditions affecting the intestines. Symptoms of IBD often resemble those of non-inflammatory conditions like irritable bowel syndrome (IBS). Calprotectin stool test is highly effective for diagnosing IBD, helping to identify patients who may need further invasive tests. It is also a reliable method for monitoring diagnosed patients, as it closely correlates with mucosal healing. High levels of calprotectin indicate active inflammation, while moderate levels may suggest mild organic disease.

In managing IBD, monitoring biologics trough levels (TDM) is a standard part of IBD treatment follow-up. BÜHLMANN provides a comprehensive range of products to support IBD treatment decisions. Additionally, BÜHLMANN is a leading provider of rapid lateral flow tests for measuring biologic trough levels and testing for anti-biologic antibodies, enhancing the precision and convenience of IBD patient care.

BÜHLMANN Calprotectin Assays and TDM Testing

BÜHLMANN is the gold standard for IBD diagnosis and monitoring offering the largest product portfolio of calprotectin testing and TDM rapid tests for biologics in IBD. The product portfolio includes the FDA cleared BÜHLMANN fCAL® turbo for high throughput testing. The immuno-turbidimetric fecal calprotectin assay BÜHLMANN fCAL® turbo provides flexible and random-access applications on all major clinical chemistry platforms. The assay allows short turnaround time from fecal sample to the reportable result. The combination of the test with the CALEX® Cap extraction device or the fecal home extraction kit CALEX® Cap Collection Set strongly simplifies the cumbersome procedure for stool pre-analytics and is adapted to be applied on clinical chemistry analyzers. BÜHLMANN also offers the FDA cleared market leader BÜHLMANN fCAL® ELISA and the Quantum Blue® calprotectin rapid tests. Further to that, the portfolio includes IBDoc®, a highly successful IBD home test for patients using an app that transforms smartphones into a calprotectin test reading device.

The BÜHLMANN Quantum Blue® rapid test combines the simplicity and speed of lateral flow technology with quantitative measurement capabilities through a small reading device. The Quantum Blue® Reader provides a quantitative value within minutes and is therefore an ideal tool in a point-of-care setting. The BÜHLMANN product line offers two different fecal calprotectin test ranges suitable for IBD diagnosis and therapy follow-up of IBD patients. Besides calprotectin assays, the Quantum Blue® portfolio includes therapeutic drug monitoring of anti-TNFα biologics on the Quantum Blue® Reader.

Learn more

IBDoc® is the first in vitro diagnostic home testing device measuring the inflammatory marker fecal calprotectin at home. The IBDoc® app turns a smartphone into a test cassette reader using state of the art image processing. Stool extraction is performed using the CALEX® Valve that is characterized by its simple and convenient handling of stool samples. The secure data connection between the IBDoc® app and the IBDoc® Portal allows Health Care Professionals to directly monitor patient results. The IBDoc® Portal also includes an application programming interface (API) that directly transfers test results into electronic patient records (EHR) or laboratory information systems (LIMS) via a common web standard or HL7 based interface.

Learn more

The CALEX® Cap Collection Set allows stool collection at the patient’s home, in order to further simplify the complete stool extraction procedure. It is fully compatible with the BÜHLMANN fecal calprotectin and p-elastase assays and provides the laboratory with a ready-to-use extract for safe, fast, and reliable analyte measurements. The CALEX® Cap extraction device offers an efficient, convenient, and hygienic home stool collection.

Learn more

BÜHLMANN CALEX® Cap extraction device offers an efficient, convenient, and hygienic stool extraction. Its simple design makes it an ideal extraction device characterized by high safety standards and by offering high stability of stool samples. Furthermore, the CALEX® Cap is fully compatible with total laboratory automation (TLA) solutions increasing speed of sample processing and reducing hands-on time.

Learn more

The new assay BÜHLMANN fPELA® turbo and the well-established BÜHLMANN fCAL® turbo together with the CALEX® Cap have revolutionized fecal testing of pancreatic elastase and calprotectin. Both turbidimetric immunoassays can be easily applied for a wide choice of clinical chemistry analyzers, providing TLA with fast turn-around-time (TAT) and optimizing laboratory workflow.

Learn more

The BÜHLMANN sCAL® turbo turbo assay is a flexible and powerful tool to be applied on most clinical chemistry analyzers for measurement of serum calprotectin. The turbidimetric technology allows rapid and flexible random-access options offering high throughput in the routine laboratory. Another major asset of the BÜHLMANN sCAL® turbo assay is the dramatically reduced hands-on time compared to other technologies, allowing serum calprotectin result reporting within a very short time.

Learn more

BÜHLMANN launched its first assay for fecal calprotectin testing more than 15 years ago and owns the gold standard with the BÜHLMANN fCAL® ELISA. Two protocols are available with the BÜHLMANN fCAL® ELISA to cover different calprotectin ranges for IBD diagnosis and monitoring.

Learn more

Contact us:

10 + 8 =